Superworth

aTYR PHARMA INC EPS ATYR

Diluted earnings per share by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
−$24.80
Latest quarter, Q2 FY26
−$4.40
Fiscal year 2025
−$31.60

aTYR PHARMA INC's earnings per share was −$24.80 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$4.40.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$31.60n/a
FY2024−$34.80n/a
FY2023−$38.40n/a
FY2022−$64.00n/a
FY2021−$75.20n/a
FY2020−$63.20n/a
FY2019−$294.00n/a
FY2018−$647.60n/a
FY2017−$1058.40n/a
FY2016−$1366.40n/a
FY2015−$6333.60n/a
FY2014−$16648.80n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$4.40n/a−$24.80
Q1 FY26−$4.40n/a−$29.20
Q4 FY25−$5.60n/a−$31.60
Q3 FY25−$10.40n/a−$33.20
Q2 FY25−$8.80n/a−$32.00
Q1 FY25−$6.80n/a−$32.40
Q4 FY24−$7.20n/a−$34.80
Q3 FY24−$9.20n/a−$37.60
Q2 FY24−$9.20n/a−$36.40
Q1 FY24−$9.20n/a−$36.00
Q4 FY23−$10.00n/a−$38.40
Q3 FY23−$8.00n/a−$38.80

Against its peers

Companies in Healthcare nearest aTYR PHARMA INC's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ATYRaTYR PHARMA INC−$24.80
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on aTYR PHARMA INC

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.